Logotyp: till Uppsala universitets webbplats

uu.sePublikationer från Uppsala universitet
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Are men under-treated and women over-treated with antidepressants?: Findings from a cross-sectional survey in Sweden
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaci. Univ Gävle, Fac Hlth & Occupat Studies, Dept Hlth & Caring Sci. (pharmacoepidemiology)ORCID-id: 0000-0003-4877-506X
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaci. (Farmakoepidemiologi)
Univ Gävle, Fac Hlth & Occupat Studies, Dept Hlth & Caring Sci, Gävle, Sweden.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för farmaci. (Farmakoepidemiologi)
2017 (Engelska)Ingår i: BJPsych bulletin, ISSN 2056-4694, E-ISSN 2056-4708, Vol. 41, nr 3, s. 145-150Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Aims and method: To examine gender differences in self-reported depression and prescribed antidepressants (ADs). The Hospital Anxiety and Depression Scale was used to assess depression, and information on prescribed ADs was obtained from the Swedish Prescribed Drug Register.

Results: Depression was reported by 11.7% of the participants (12.3% men and 11.2% women). ADs were prescribed for 7.6% of the participants (5.3% men, 9.8% women). Among men, 1.8% reported depression and used ADs, 10.5% reported depression but did not use ADs, and 3.6% used ADs but did not report depression. The corresponding figures for women were 2.6%, 8.6% and 7.2%.

Clinical implications: Men report depression to a greater extent than women but are prescribed ADs to a lesser extent, possibly a sign of under-treatment. Women are prescribed ADs without reporting depression more often than men, possibly a sign of over-treatment. Although the causes remain unclear, diagnostic and treatment guidelines should benefit from considering gender differences in these respects.

Ort, förlag, år, upplaga, sidor
2017. Vol. 41, nr 3, s. 145-150
Nyckelord [en]
Self-reported depression, Antidepressants, Gender differences, Over-treatment, Under-treatment
Nationell ämneskategori
Farmaceutiska vetenskaper Psykiatri
Forskningsämne
Farmakoepidemiologi
Identifikatorer
URN: urn:nbn:se:uu:diva-310328DOI: 10.1192/pb.bp.116.054270ISI: 000407961600004PubMedID: 28584650OAI: oai:DiVA.org:uu-310328DiVA, id: diva2:1056125
Tillgänglig från: 2016-12-14 Skapad: 2016-12-14 Senast uppdaterad: 2019-12-13Bibliografiskt granskad
Ingår i avhandling
1. The influence of gender and depression on drug utilization: Pharmacoepidemiological research in Sweden
Öppna denna publikation i ny flik eller fönster >>The influence of gender and depression on drug utilization: Pharmacoepidemiological research in Sweden
2017 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Background Drug use has increased over recent decades, and is especially great among women and among people with mental health problems. To take advantage of the full potential of drugs and to avoid drug-related problems, drug prescription needs to be correct and the drugs need to be taken according to the prescribed regimens. Research on drug utilization is thus important to the public health.

Aim To study the influence of gender and depression on drug utilization, prescription of drugs and self-reported use of drugs, i.e. adherence.

Methods The thesis included two population-based questionnaires and data from the Swedish Prescribed Drug Register (SPDR) covering Swedish citizens 18-84 years. The questionnaire in Study I and II included items on prescription drug use and adherence to treatment regimens; Study II also included the Hospital Anxiety and Depression Scale (HADS) for self-estimation of anxiety/depression. The questionnaire in Study III included the HADS and data from the SPDR on prescribed antidepressants. Study IV included data from the SPDR on all types of prescribed drugs.

Results Men and women differed in non-adherent behaviours and reasons for non-adherence, for example, men were more likely to report forgetting to take the drug, while women were more likely to report adverse drug reactions (ADRs) as a reason for non-adherence. Further, both anxiety and depression were associated with non-adherence and with ADRs as a reason for non-adherence. In addition, men reported depression to a greater extent than women did but used antidepressants to a lesser extent, while women used antidepressants without reporting depression more often than men did, which may be a sign of under-treatment among men and over-treatment among women. Moreover, the associations between antidepressants and other types of drugs differed by gender; they were often specific, or stronger, in women than in men, which may be a sign of a gender difference in comorbidity between depression and other conditions.

Conclusions Although the cross-sectional study design prevented confirmation of causality, the thesis found that gender and depression influence both prescription of drugs and adherence, and are thus important to pay attention to in clinical practice as well as research.

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2017. s. 67
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 238
Nyckelord
adherence, anxiety, depression, drug utilization, gender, pharmacoepidemiology, prescription drugs, self-report
Nationell ämneskategori
Medicin och hälsovetenskap
Forskningsämne
Farmakoepidemiologi
Identifikatorer
urn:nbn:se:uu:diva-330136 (URN)978-91-513-0088-7 (ISBN)
Disputation
2017-11-24, Sal IV, Universitetshuset, Biskopsgatan 3, Uppsala, 09:15 (Svenska)
Opponent
Handledare
Tillgänglig från: 2017-11-01 Skapad: 2017-10-04 Senast uppdaterad: 2017-11-01

Open Access i DiVA

fulltext(103 kB)378 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 103 kBChecksumma SHA-512
2057978c572aa4880f53522ea02916c8d2889d9a3ac7cc28f32c76ab1cd20f800feda2cb06f2ecb7a618b6e515dfe33ca8a45721409924f1dd4a85614ee31b61
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Person

Thunander Sundbom, LenaBingefors, KerstinIsacson, Dag

Sök vidare i DiVA

Av författaren/redaktören
Thunander Sundbom, LenaBingefors, KerstinIsacson, Dag
Av organisationen
Institutionen för farmaci
I samma tidskrift
BJPsych bulletin
Farmaceutiska vetenskaperPsykiatri

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 379 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 604 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf